Erasca ERAS
NASDAQ ERAS
$14.84 +0.22 (+1.50%)
As of: Oct 21, 2026 · 10:40 AM EDT

Erasca (ERAS) EBITDA Margin (2020 - 2026)

Updated

Analysis

Erasca (ERAS) EBITDA Margin (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,131.65 Bn 1,100.24 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 615.89 Bn 534.41 Bn 17.26 Bn 35.95%
3 AbbVie 505.03 Bn 478.14 Bn 12.70 Bn 49.01%
4 Merck 368.78 Bn 323.16 Bn 12.21 Bn 6.02%
5 Novartis Ag 298.66 Bn 262.65 Bn 11.24 Bn -
6 Astrazeneca 262.09 Bn 235.78 Bn 12.86 Bn 33.11%
7 Amgen 236.57 Bn 191.97 Bn 7.24 Bn 46.01%
8 Gilead Sciences 191.05 Bn 165.25 Bn 6.22 Bn -124.26%
9 Pfizer 170.60 Bn 117.25 Bn 10.94 Bn 39.16%
10 Erasca 4.63 Bn 3.56 Bn - -1,301.78%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,301.78%
Mar 31, 2026 -4,207.42%
Dec 31, 2025 -894.48%
Sep 30, 2025 -850.94%
Jun 30, 2025 -862.31%
Mar 31, 2025 -734.35%
Dec 31, 2024 -660.74%
Sep 30, 2024 -620.21%
Jun 30, 2024 -1,322.79%
Mar 31, 2024 -970.59%
Dec 31, 2023 -777.25%
Sep 30, 2023 -775.82%
Jun 30, 2023 -823.69%
Mar 31, 2023 -931.93%
Dec 31, 2022 -4,765.29%
Sep 30, 2022 -2,377.86%
Jun 30, 2022 -9,116.24%
Mar 31, 2022 -31,668.42%
Dec 31, 2021 -38,410.00%
Sep 30, 2021 -93,577.55%
API Access

Erasca EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ERAS&period=max&api_key=YOUR_API_KEY